Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2015

Sep 11, 2015

30198_dirs_2015-09-11_51a347f7-2393-41d4-bf15-7cb5dc24ff15.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-09-09

Reporting Person: LISTER JOHN (Sr. VP, General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-09 Common Stock D 5725.0 $90.8985 Disposed 115622 Direct

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 75,834 unvested restricted stock units 37,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 32,500 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 5,834 of which were granted on March 11, 2013 and shall vest through March 11, 2016.